Amanote Research
Register
Sign In
Topical Antibiotics and Intravitreal Injections
Acta Ophthalmologica
- United States
doi 10.1111/aos.13417
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Ophthalmology
Date
April 25, 2017
Authors
Alex P. Hunyor
Rohan Merani
Archie Darbar
Jean-François Korobelnik
Paolo Lanzetta
Annabelle A. Okada
Publisher
Wiley
Related search
Risk of Endophthalmitis After Intravitreal Drug Injection When Topical Antibiotics Are Not Required
Archives of Ophthalmology
Endophthalmitis Rate Following Intravitreal Injection of Anti‐VEGF and the Impact of Post‐injection Topical Antibiotics
Acta Ophthalmologica
Medicine
Ophthalmology
Feasibility of Intravitreal Erythropoietin Injections in Humans
British Journal of Ophthalmology
Molecular Neuroscience
Ophthalmology
Sensory Systems
Cellular
Case of Endophthalmitis Following Intravitreal Injections of Bevacizumab
Clinical Ophthalmology
Ophthalmology
Short-Term Complications of Intravitreal Injections of Triamcinolone and Bevacizumab
Eye
Medicine
Arts
Sensory Systems
Ophthalmology
Humanities
Initial Dose of Three Monthly Intravitreal Injections Versus PRN Intravitreal Injections of Bevacizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion
BioMed Research International
Immunology
Molecular Biology
Biochemistry
Microbiology
Medicine
Genetics
Laponite Clay for Long Term Delivery Dexamethasone Intravitreal Injections
Acta Ophthalmologica
Medicine
Ophthalmology
Topical Anesthesia With Ropivacaine and Proparacaine for Intravitreal Injection Procedures
Journal of Ophthalmology & Clinical Research
Outcome of Intravitreal Bevacizumab Injection Without Pre and Postoperative Antibiotics
BMC Ophthalmology
Medicine
Ophthalmology